Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma.
Hiroki IshiharaHidekazu TachibanaToshio TakagiTsunenori KondoHironori FukudaKazuhiko YoshidaJunpei IizukaHirohito KobayashiMasayoshi OkumiHideki IshidaKazunari TanabePublished in: Targeted oncology (2020)
The systemic inflammatory factors NLR, MLR, and CRP were predictive factors in nivolumab therapy for mRCC. These easily monitored factors can contribute to effective treatment and follow-up.